pre-IPO PHARMA

COMPANY OVERVIEW

Noden Pharma DAC is a global specialty pharmaceutical company that is focused on acquiring prescription medicines across a broad range of therapeutic areas in international markets. The company focuses its resources on acquiring and optimizing established medicines.


LOCATION

  • Dublin, , Ireland
  • Boston, MA, USA

  • THERAPEUTIC AREAS

  • Cardiovascular Disease

  • WEBSITE

    https://www.prnewswire.com/news-releases/pdl-biopharma-commits-to-equity-investment-in-noden-pharma-for-the-acquisition-of-tekturna-aliskiren-and-tekturna-hct-aliskiren-and-hydrochlorothiazide-300274041.html


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Sep 9, 2020

    PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital


    Jul 30, 2020

    PDL BioPharma Enters Into Agreement for the Divestiture of the Noden Pharmaceutical Business to Stanley Capital


    Nov 15, 2017

    Noden Pharma Announces FDA Approval of Tekturna(aliskiren) Oral Pellets for the Treatment of Hypertension in Adults and Children 6 Years of Age and Older


    Jun 5, 2017

    Noden Pharma Notified of ANDA Filing for Tekturna


    For More Press Releases


    Google Analytics Alternative